| Total (n = 830) | CONUT score | p value | ||
---|---|---|---|---|---|
0/1 (n = 508, 61%) | 2/3 (n = 249, 30%) | ≥4 (n = 73, 9%) | |||
Age, years | Â | Â | Â | Â | 0.022 |
 median (range) | 78 (75–94) | 78 (75–92) | 79 (75–94) | 80 (75–88) |  |
Sex | Â | Â | Â | Â | 0.115 |
 Male | 470 (57%) | 277 (55%) | 144 (58%) | 49 (67%) |  |
 Female | 360 (43%) | 231 (45%) | 105 (42%) | 24 (33%) |  |
BMI | Â | Â | Â | Â | 0.055 |
  < 25 | 681 (82%) | 408 (80%) | 206 (83%) | 67 (92%) |  |
  ≥ 25 | 149 (18%) | 100 (20%) | 43 (17%) | 6 (8%) |  |
Primary tumor site | Â | Â | Â | Â | 0.380 |
 Colon | 653 (79%) | 398 (78%) | 193 (78%) | 62 (85%) |  |
 Rectum | 177 (21%) | 110 (22%) | 56 (22%) | 11 (15%) |  |
Stage | Â | Â | Â | Â | 0.045 |
 I | 224 (27%) | 152 (30%) | 59 (24%) | 13 (18%) |  |
 II | 258 (31%) | 152 (30%) | 77 (32%) | 29 (40%) |  |
 III | 258 (31%) | 159 (31%) | 80 (32%) | 19 (26%) |  |
 IV | 90 (11%) | 45 (9%) | 33 (13%) | 12 (16%) |  |
ASA-PS |  |  |  |  | < 0.001 |
 1 | 98 (12%) | 71 (14%) | 22 (9%) | 5 (7%) |  |
 2 | 571 (69%) | 360 (71%) | 175 (70%) | 36 (49%) |  |
 3 | 161 (19%) | 77 (15%) | 52 (21%) | 32 (44%) |  |
CCI | Â | Â | Â | Â | 0.001 |
 2 | 532 (64%) | 345 (68%) | 151 (61%) | 36 (49%) |  |
 3 | 156 (19%) | 95 (19%) | 48 (19%) | 13 (18%) |  |
 ≥ 4 | 142 (17%) | 68 (13%) | 50 (20%) | 24 (33%) |  |
NIA/NCI | Â | Â | Â | Â | 0.001 |
 0/1 | 376 (45%) | 246 (48%) | 100 (40%) | 30 (41%) |  |
 2/3 | 381 (46%) | 233 (46%) | 119 (48%) | 29 (40%) |  |
 ≥ 4 | 73 (9%) | 29 (6%) | 30 (12%) | 14 (19%) |  |
ACE-27 | Â | Â | Â | Â | 0.130 |
 Normal | 0 | 0 | 0 | 0 |  |
 Mild | 0 | 0 | 0 | 0 |  |
 Moderate | 487 (59%) | 310 (61%) | 133 (53%) | 44 (60%) |  |
 Severe | 343 (41%) | 198 (39%) | 116 (47%) | 29 (40%) |  |